Form 4 for TMDX TransMedics Group, Inc.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-25 · accession 0001193125-25-300644 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-26 | 2025-11-25 | TMDX | Ranganath Anil P. | See remarks | S - Sale+OE | $145.22 | -3,000 | 14.0K | -18% | -$435.7K |
| D | 2025-11-26 | 2025-11-25 | TMDX | Ranganath Anil P. | See remarks | M - OptEx | $93.88 | +3,000 | 17.0K | +21% | +$281.6K |
| D | 2025-11-26 | 2025-11-25 | TMDX | Ranganath Anil P. | See remarks | M - OptEx | $0.00 | -3,000 | 7,420 | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-25 | S | D | 3,000 | $145.22 | 13,955 | D | — | — | (F1) The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $145.00 to $145.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 2 | Common | Common Stock | 2025-11-25 | M | A | 3,000 | $93.88 | 16,955 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-11-25 | M | D | 3,000 | $0.00 | 7,420 | D | $93.88 · — to 2033-08-01 | 3,000 Common Stock | (F2) The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. |